Insights

GPCR Focus Targeting a large and underserved GPCR space, Design Pharmaceuticals offers a high-throughput, cell-based multiplex GPCR screening platform that could accelerate partner drug discovery programs seeking novel GPCR targets or improved hit rates.

Scale Advantage platform enables screening of hundreds of GPCR targets across 300+ cell lines with NGS readouts, offering potential for collaborators to achieve faster hit identification and deeper exploration of drug space with reduced compound requirements.

Modality Agnostic Capabilities span small molecules, peptides, and antibody libraries, allowing BD teams to propose partnerships across multiple modalities and to integrate with existing therapeutic programs without changing core discovery workflows.

Early Stage Partnerships With sub-$1M revenue and recent $5M funding, the company is likely prioritizing collaborative R&D deals, grants, or milestone-based partnerships to de-risk early programs in exchange for equity or upfront collaboration fees.

Innovation Narrative Advanced droplet microfluidics and living-cell functional assays position the company as a tech-forward partner for pharma companies seeking to outpace traditional screening methods and to explore isoforms and mutants for precision targeting.

Similar companies to Design Pharmaceuticals Inc.

Design Pharmaceuticals Inc. Tech Stack

Design Pharmaceuticals Inc. uses 8 technology products and services including Cloudflare Web Optimizations, Cloudflare, Squarespace, and more. Explore Design Pharmaceuticals Inc.'s tech stack below.

  • Cloudflare Web Optimizations
    Analytics
  • Cloudflare
    Content Management System
  • Content Management System
  • Content Management System
  • MySQL
    Database
  • Animate.css
    UI Frameworks
  • Nginx
    Web Servers
  • Magnific Popup
    Web Tools And Plugins

Design Pharmaceuticals Inc.'s Email Address Formats

Design Pharmaceuticals Inc. uses at least 2 email formats:
Design Pharmaceuticals Inc. Email FormatsExamplePercentage
F.Last@designpharmaceuticals.comJ.Doe@designpharmaceuticals.com
92%
FirstL@designpharmaceuticals.comJohnD@designpharmaceuticals.com
8%

Frequently Asked Questions

What is Design Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s official website is designpharmaceuticals.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Design Pharmaceuticals Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Design Pharmaceuticals Inc.'s annual revenue is estimated to be <$1M.

What is Design Pharmaceuticals Inc.'s NAICS code?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Design Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Design Pharmaceuticals Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Senior Director R&d Compound Development: X. Y. and Board Member: R. N. Explore Design Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does Design Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Design Pharmaceuticals Inc. use?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s tech stack includes Cloudflare Web Optimizations, Cloudflare, Squarespace, WordPress, MySQL, Animate.css, Nginx and Magnific Popup.

What is Design Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s email format typically follows the pattern of F.Last@designpharmaceuticals.com. Find more Design Pharmaceuticals Inc. email formats with LeadIQ.

How much funding has Design Pharmaceuticals Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Design Pharmaceuticals Inc. has raised $5M in funding. The last funding round occurred on Apr 12, 2022 for $5M.
Design Pharmaceuticals Inc. logo

Design Pharmaceuticals Inc.

Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees

Design Pharmaceuticals Inc. is a Cambridge, Massachusetts-based pharmaceutical manufacturing company focused on accelerating GPCR drug discovery through ultra-high throughput bioscience technologies. Its platform aims to broaden functional screening across a wide range of GPCR targets, enabling the identification of hit candidates more efficiently and with reduced compound requirements, while also allowing analysis of potential off-target effects. The approach is modality agnostic, supporting small molecules, peptides, or antibody libraries, and can be adapted to include GPCR variants for drug function assays. Customers are researchers and teams seeking faster exploration of drug space within the GPCR field, addressing diseases that currently lack satisfactory therapies. The company positions itself within the biotechnology landscape as a specialized screening and discovery engine, leveraging a cell-based, multiplex GPCR screening capability to advance functional readouts in living cells, with ongoing development in droplet microfluidics to scale screening of large libraries.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $5M

    Design Pharmaceuticals Inc. has raised a total of $5M of funding over 1 rounds. Their latest funding round was raised on Apr 12, 2022 in the amount of $5M as a Seed.

  • <$1M

    Design Pharmaceuticals Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.